Vanguard Group’s Agile Therapeutics AGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $39.9K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $17.2K | Hold |
|
|||||
|
2022
Q4 | $17.4K | Buy |
|
|||||
|
2022
Q3 | $9K | Sell |
|
|||||
|
2022
Q2 | $35K | Sell |
|
|||||
|
2022
Q1 | $812K | Sell |
|
|||||
|
2021
Q4 | $2.19M | Buy |
|
|||||
|
2021
Q3 | $3.95M | Hold |
|
|||||
|
2021
Q2 | $5.46M | Sell |
|
|||||
|
2021
Q1 | $9.11M | Buy |
|
|||||
|
2020
Q4 | $12.6M | Buy |
|
|||||
|
2020
Q3 | $11.6M | Sell |
|
|||||
|
2020
Q2 | $10.9M | Buy |
|
|||||
|
2020
Q1 | $6.34M | Buy |
|
|||||
|
2019
Q4 | $6.53M | Buy |
|
|||||
|
2019
Q3 | $2.75M | Buy |
|
|||||
|
2019
Q2 | $2.53M | Buy |
|
|||||
|
2019
Q1 | $1.14M | Buy |
|
|||||
|
2018
Q4 | $404K | Sell |
|
|||||
|
2018
Q3 | $401K | Buy |
|
|||||
|
2018
Q2 | $534K | Buy |
|
|||||
|
2018
Q1 | $2.65M | Buy |
|
|||||
|
2017
Q4 | $2.67M | Buy |
|
|||||
|
2017
Q3 | $2.99M | Buy |
|
|||||
|
2017
Q2 | $2M | Sell |
|
|||||
|
2017
Q1 | $2.57M | Buy |
|
|||||
|
2016
Q4 | $2.54M | Buy |
|
|||||
|
2016
Q3 | $2.85M | Buy |
|
|||||
|
2016
Q2 | $2.87M | Buy |
|
|||||
|
2016
Q1 | $2.33M | Buy |
|
|||||
|
2015
Q4 | $1.35M | Buy |
|
|||||
|
2015
Q3 | $774K | Buy |
|
|||||
|
2015
Q2 | $606K | Buy |
|
|||||
|
2015
Q1 | $258K | Buy |
|
|||||
|
2014
Q4 | $119K | Buy |
|